Investing

Investors want proof AI will aid drug discovery. Evidence may come in the second half

Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI to discover new drugs.

adminadmin
Jul 6, 2024 - 20:00
 0  18
Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI to discover new drugs.
Read More

Tags:

Previous Article

Here are the top stocks to own for the second half, according to BTIG

Next Article

These stocks, including Nvidia, have more room to run in July, Bank of America says

admin
admin

Related Posts

Top 10 colleges for financial aid, according to The Princeton Review — one is in the Ivy League

Top 10 colleges for financial aid, according to The Pri...

admin Aug 28, 2024  0  14

These stocks beat earnings and should outperform in months ahead, Wolfe Research says

These stocks beat earnings and should outperform in mon...

admin Oct 30, 2024  0  6

Here's when exchange-traded funds really flex their ‘tax magic’ for investors

Here's when exchange-traded funds really flex their ‘ta...

admin Oct 23, 2024  0  11